2016_Head & Neck COURSE BOOK

Influence of p16/HPV on radiotherapy outcome in HNSCC  (5fx/week) Disease‐specific survival DAHANCA 5 (N=156)

Loco‐regional tumour control

0.36 (0.20 ‐ 0.64)

Overall survival

0.35 (0.19 ‐ 0.64)

0.44 (0.28 ‐ 0.68)

Lassen et al. JCO 27:1992‐98,2009